Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Zoetis (NYSE:ZTS)
/Idexx%20Laboratories%2C%20Inc_%20phone%20and%20logo-%20by%20T_Schneider%20via%20Shutterstock.jpg)
Despite outperforming the broader S&P 500 Index over the past year, analysts maintain a cautiously optimistic outlook on IDEXX Laboratories’ future prospects.
2 Healthcare Stocks with Solid Fundamentals and 1 Facing Challenges
Zoetis Inc. (NYSE:ZTS) today announced that Kristin Peck, Chief Executive Officer, will participate in a fireside chat at the KeyBanc Capital Markets Healthcare Forum on Tuesday, March 17, 2026...
Zoetis Inc. (NYSE:ZTS) today announced that Wetteny Joseph, Executive Vice President and Chief Financial Officer, will participate in fireside chats at the following investor conferences. ...
Acquisition strengthens Zoetis’ leadership in Precision Animal Health by integrating Neogen’s global genomics capabilities, expanding predictive insights and individualized care worldwide
/Zoetis%20Inc%20logo%20on%20phone-by%20viewimage%20via%20Shutterstock.jpg)
Zoetis has underperformed the healthcare sector over the past year, and analysts remain moderately optimistic about the stock’s outlook.
Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Securities 2026 Animal Health Summit on Thursday, February 26, 2026 at 1:15 p.m. ET. Wetteny Joseph, Executive Vice President and...
The Top 5 Analyst Questions From Zoetis’s Q4 Earnings Call